Viewing data from:

PHILITH

ANDA

ETHINYL ESTRADIOL; NORETHINDRONE | A090947 | NOVAST LABORATORIES LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: TRI-NORINYL 28-DAY(TE code: AB)

Medicare Part D Spending

CMS annual spending data for Philith (2023)

Total Spending

$8K

Total Claims

198

Beneficiaries

Avg Cost/Unit

$0.85

Spending Trend

$15K(2019)→$16K(2020)→$14K(2021)→$8K(2022)→$8K(2023)

YoY Change:+3.8%

5yr CAGR:-0.6%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.035MG;0.4MG

0 patents0 exclusivities▴

TABLET;ORAL-28 | Approved: Dec 22, 2011

No patent or exclusivity listings for this strength.